On December 18, 2023, Mary Thistle resigned as a member of the board of directors of Alaunos Therapeutics, Inc. with immediate effect. Ms. Thistle's resignation was not the result of any disagreement on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7001 USD | +12.54% |
|
-23.90% | -33.98% |
06-10 | BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO | MT |
05-15 | Alaunos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-33.98% | 11.21M | |
+15.19% | 121B | |
+19.91% | 114B | |
+18.52% | 23.61B | |
-19.80% | 20.43B | |
-15.52% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- TCRT Stock
- News Alaunos Therapeutics, Inc.
- Alaunos Therapeutics, Inc. Announces the Resignation of Mary Thistle as Member of the Board of Directors